Jersey, 9 February 2018: Atrium European Real Estate Limited (VSE/Euronext: ATRS), ("Atrium" or the "Company" and …
If you want a Stock Review on IART, ATRS, BDX, or WAT then come over to http://dailystocktracker.com/register and …
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies ... http://investorplace.com/2015/01/6-medical-devices-stocks-to-sell-now-atrs-csii-masi/.
If you want a Stock Review on ATRS, IART, BDX, or WAT then come over to http://dailystocktracker.com/register/ and …
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has …
and they also are very bullish on a mega-cap technology stock and a small-cap biotech. All are rated Buy at Jefferies. This small-cap biotech may prove to be a big-time winner for aggressive accounts. Antares Pharma Inc. (NASDAQ: ATRS) …
Ms. Geraldine Copeland-Wright is Group General Counsel at ATRIUM EUROPEAN REAL ESTATE LIMITED since June 14, 2013. Prior to joining the Atrium Group, Geraldine was Regions Senior Legal Advisor to Qatari Diar, the real estate …
ATRS closed Thursday's trading at $3.73, down 5.33%. In after-hours, the stock was down 41.02% to $2.20. BioDelivery Sciences International Inc. (BDSI) has entered into a Settlement Agreement with Teva Pharmaceuticals Industries Ltd. …
A year ago, they were trading at $1.53. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS